Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
James P. Moises, MD, Assistant Clinical Professor of Surgery, Department of Emergency Medicine, Clerkship Director of Emergency Medicine, Tulane University Hospital and Clinic, discusses the management for closed…
Ellen Tedaldi, MD, Professor of Internal Medicine, Director of HIV Program, Temple University School of Medicine, discusses non-compliance with HIVAIDS meds as well as ways to decrease the…
Mary Wright, MD, Associate Professor & Director, Breast Center, Section of Breast Surgery, Department of Surgery, Tulane University School of Medicine, discusses post mastectomy breast reconstructive surgery. References…
This study observed how people who were current smokers, compared with those who never smoked, were at increased risk of incident early age-related macular degeneration (AMD) and for…
The FDA has approved natalizumab (Tysabri) for the treatment of moderate-to-severe Crohn’s disease in patients with evidence of inflammation who have had an inadequate response to, or are…
The CDC’s FluView, a weekly influenza surveillance report prepared by the influenza division, posts the statistics for influenza week 6, February 3 – February 9, 2008. References and…
Gilbert E. D’Alonzo, MD, Professor of Medicine, Temple University School of Medicine, discusses heparin prophylaxis. References and Resources Chibbaro S, Tacconi L. Safety of deep venous thrombosis prophylaxis…
The FDA cleared for marketing the first replacement heart valve from donated human tissue in which the cells have been removed. References and Resources FDA Clears for Market…
